AnaptysBio, Inc. ANAB
45.73 USD -0.52 (-1.12%)
Regular-session close
45.73 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
44.69 Day range 46.23
22.01 52-week range 72.36
- YTD
- +41.49%
- 1 year
- +102.79%
News
zacks.com AnaptysBio, Inc. (ANAB) Misses Q3 Earnings and Revenue Estimates AnaptysBio, Inc. (ANAB) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.52 per share a year ago.benzinga.com AnaptysBio Q3 EPS $0.11 Misses $ 0.51 Estimate, Sales $30.274M Miss $33.186M Estimate AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $1.58 by 93.04 percent. This is a 78.85 percent decrease over earnings of $0.52…
globenewswire.com Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza…
globenewswire.com Anaptys Announces Participation in Upcoming Investor Conferences SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza…
